The company, which said it has informed regulatory authorities in affected countries Germany, the United Kingdom and the United States, said no illnesses have been reported.
Spokesman Tom Millikin described the voluntary recalls as a precaution, saying that though it could harm people with chronic lung problems or a weakened immune system, only small amounts of the B. cepacia bacteria were found in the over-the-counter product.
P&G says consumers should not use the medication and should call P&G for a refund or replacement coupon.
About EQUITIES:
Since 1951, EQUITIES Magazine has been a leading media company providing business editorial content designed to serve the needs of business leaders, professionals, institutional investors and retail investors. We are focused on business and the business of making money, not on lifestyle subjects. We publish original reporting in print and on our website, as well as select content at www.nasdaq.com. For 28 years we have hosted our own branded investor conferences that connect public company CEO’s with our loyal readers in the investment community.
Sign up for a free one-year subscription to EQUITIES Magazine
